Actovegin solution for injection

Ország: Örményország

Nyelv: angol

Forrás: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Aktív összetevők:

deproteinised haemoderivate of calf blood

Beszerezhető a:

Takeda Austria GmbH

ATC-kód:

առկա չէ (B06AB)

INN (nemzetközi neve):

deproteinised haemoderivate of calf blood

Adagolás:

40mg/ml

Gyógyszerészeti forma:

solution for injection

db csomag:

(25/5x5/) ampoules 2ml, in blister

Recept típusa:

Prescription

Engedélyezési státusz:

Registered

Engedély dátuma:

2016-09-15

Termékjellemzők

SUMMARY OF PRODUCT CHARACTERISTICS
1. NAME OF THE MEDICINAL PRODUCT
ACTOVEGIN®
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
For 2 ml ampules:
1 ampule contains: _active ingredient:_ Actovegin® concentrate (dry
mass)
1)
– 80.0
mg;
_Excipients:_ water for injections – up to 2 ml.
For 5 ml ampules:
1 ampule contains: _active ingredient:_ Actovegin® concentrate (dry
mass)
1)
– 200.0
mg;
_Excipients:_ water for injections – up to 5 ml.
For 10 ml ampules:
1 ampule contains: _active ingredient:_ Actovegin® concentrate (dry
mass)
1)
– 400.0
mg;
_Excipients:_ water for injections – up to 10 ml.
1)
Actovegin® concentrate contains Sodium Chloride as Sodium and
Chlorine
shaped ion which is calf blood components. Sodium Chloride is not
added or
removed within the process production. Content of Sodium Chloride
compunds
about 53.6 mg (for 2 ml ampules), about 134.0 mg (for 5 ml ampules)
and around
268.0 mg (for 10 ml ampules).
3. PHARMACEUTICAL FORM
Solution for injection
4. CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
As part of combined therapy:

Symptomatic
treatment
of
cognitive
impairment
including
post-stroke
cognitive impairment and dementia;

Symptomatic treatment of peripheral perfusion disorders and their
sequelae;

Symptomatic treatment of diabetic polyneuropathy (DPN).
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Actovegin® solution for injections is used for intra-arterial,
intravenous (including
infusions) and intramuscular administration.
Directions for use of one-point-cut ampoules
Hold
the
ampoule
with
the colored dot facing up.
Make sure to remove all
the liquid from the top of
the
ampoule
by
gently
shaking
and
tapping
it
with a finger.
Hold the ampoule with the
colored
dot
facing
up.
Snap the ampoule tip
as
shown in the picture.
Corresponding to the severity of the clinical picture, initially 10-20
ml i.v. or i.a.
daily; for further treatment, 5 ml i.v. or slowly i.m. daily or
several times a week.
For administration as infusion, 10-50 ml is added to 200-300 ml basic
solution
(blood